Holzkirchen, Germany, February 24, 2014 – Sandoz officially opened its representative office in Accra, Ghana on January 23, 2014.The ceremony was attended by healthcare professionals including pharmacists, doctors, the Ghana health service, the Ministr…
February 17, 2014 – Sandoz has been recognized by various organizations for its achievements in creating an inclusive workplace. …
Holzkirchen, Germany, February 12, 2014 – Sandoz announced it has received marketing authorization in Belgium for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD.The product was first approved in Denmark on December 18…
Holzkirchen, Germany, February 10, 2014 – Sandoz announced today it has received Norwegian marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD.The product was first approved in Denmark on Decemb…
Princeton, New Jersey, February 5, 2014 – Sandoz today announced the US launch of doxercalciferol injection vials, the first generic version of Genzyme’s Hectorol®.Doxercalciferol injection vials are indicated for the treatment of secondary hyperparath…
February 4, 2014 – Today Sandoz recognizes World Cancer Day. Cancer is a leading cause of death worldwide, accounting for 7.6 million deaths (around 13% of all deaths) in 2008, according to the World Health Organization. Deaths from cancer worldwide ar…
Holzkirchen, Germany, February 4, 2014 – Sandoz announced today it has received Bulgarian marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD.The product was first approved in Denmark on Decembe…
Basel, January 29, 2014 – Novartis delivers strong sales and innovation in 2013; underlying business performance reinforces growth prospects.Read the media release …
Holzkirchen, Germany, January 29, 2014 – Sandoz announced today it has received Romanian marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD.The product was first approved in Denmark on December…
Holzkirchen, Germany, January 29, 2014 – Sandoz announced today it has received Romanian marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD.The product was first approved in Denmark on December…